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Enhancement of cartilage repair through
the addition of growth plate chondrocytes
in an immature skeleton animal model
Ryszard Tomaszewski1,2, Łukasz Wiktor1* and Artur Gap1
Abstract
Background: The treatment of articular cartilage damage is a major clinical problem. More often, this clinical issue
affects children, which forces doctors to find the best treatment method.
Methods: The aim of this experimental study on 2-month-old Landrace pigs was to compare the results of two
cartilage defect treatments: (1) filling the cartilage defect with a scaffold incubated with bone marrow aspirate
supplemented with growth plate chondrocytes (the CELLS group) and (2) filling the cartilage defect with an empty
scaffold implanted after drilling the subchondral bone (the CTRL group). The treatment outcomes were assessed
macroscopically and microscopically.
Results: Based on the macroscopic evaluation, all animals showed a nearly normal morphology, with an average of
9.66/12 points (CTRL) and 10.44/12 points (CELLS). Based on the microscopic evaluation, 1 very good result and 8
good results were obtained in the CTRL group, with an average of 70.44%, while 5 very good results and 4 good
results were obtained in the CELLS group, with an average of 79.61%.
Conclusions: (1) Growth plate chondrocytes have high chondrogenic potential and thus offer new possibilities for
cartilage cell therapy. (2) The implantation of a scaffold loaded with bone marrow-derived MSCs (mesenchymal
stem cells) and growth plate chondrocytes into a cartilage defect is a good therapeutic method in immature
patients. (3) Cartilage repair based on a scaffold with bone marrow aspirate-derived cells supplemented with
autologous growth plate chondrocytes achieves better results than repair with marrow stimulation and a hyaluronic
acid-based scaffold (overall microscopic rating). (4) Chondrocyte clustering is a manifestation of the cartilage repair
process but requires further observation.
Keywords: Articular cartilage, Chondrocyte, Trauma, Histological scoring system
Background
Due to its specific structure and highly specialised func-
tion, the treatment of damage to articular cartilage is a
major clinical problem. Moreover, its structure, which
consists of chondrocytes surrounded by an extracellular
matrix, and its avascular character result in a low regen-
erative capacity. The chondron framework and orienta-
tion are closely associated with the microarchitecture,
function, and location of articular cartilage, which
further complicates the regeneration process. A number
of different treatment methods have been developed for
both early and advanced stages of cartilage damage, but
a definitive method has not yet been determined. Among
all of the surgical procedures used for the treatment of
cartilage damage, the following should be distinguished:
arthroscopic debridement, bone marrow stimulation,
osteochondral autografting, autologous chondrocyte
implantation (ACI), and matrix-induced autologous
chondrocyte implantation (MACI) [1, 2]. The continu-
ous development of regenerative medicine creates new
possibilities for cartilage defect treatments involving cell
therapy. Isolated and specially cultured cells can be
injected into the joint, or via tissue engineering tech-
niques, and can be implanted on special substrates
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directly in the site of cartilage damage. A variety of cells
have been used, as reported in the literature, including
autogenic chondrocytes, allogenic chondrocytes, mesen-
chymal stem cells (MSCs; most widely used; can be de-
rived from bone marrow, blood, synovium, and synovial
fluid), and human pluripotent stem cells (embryonic
stem cells, ESCs; induced pluripotent stem cells, iPSCs);
however, the best cells have yet to be identified [3–12].
The aim of our study was to compare the effects of
treating cartilage damage with the two currently most
popular techniques: marrow stimulation and autologous
cell therapy. We chose the marrow stimulation tech-
nique as a reference point because it is a one-step
method that does not require expensive instrumentation
and has been widely used for many years. Based on the
current literature, cell therapies are rapidly developing,
with promising results [3]. Chondrocytes and MSCs are
the most commonly used cells in cartilage tissue engin-
eering [2, 4]. In our opinion, the key point is to find a
simple and optimal one-step surgical cartilage repair
technique that restores hyaline cartilage. Due to the
aforementioned facts, our study was designed to evaluate
the effects of biological therapy based on the use of bone
marrow-derived MSCs along with young chondrocytes
isolated from growth plates. The proposed method com-
bines the MACI technique with the clinical application
of MSCs.
Our research was carried out using a developmental
animal model because in everyday practice, we more
often diagnose articular cartilage injuries in children in
the Orthopedics Department. We wanted to focus on
immature animals to mimic cartilage repair in children.
Cartilage regeneration potential in children has been de-
scribed to be more potent compared with adult patients.
Moreover, children and adolescents have a greater
capacity to spontaneous cartilage healing which corres-
pond with better outcome, both after conservative and
surgical treatment. Due to abovementioned, problem of
cartilage damage in children should always be consid-
ered individually.
Materials and methods
The study group consisted of 10 pigs at the age of 12
weeks. Each animal was assigned a number, and the
knee joints were divided into right (R) and left (L). Both
hind legs of all animals were operated on; one side was
treated with a hyaluronic acid-based scaffold and bone
marrow cells via the marrow stimulation technique (the
CTRL group), and the other side was treated with bone
marrow cells from marrow aspirates supplemented with
immature chondrocytes isolated from growth plates (the
CELLS group). In the first stage of the experiment, in
the operating room with the animal under analgoseda-
tion (atropine sulphate 0.05 mg/kg s.c., Polfarmex,
Kutno; ketamine hydrochloride 3 mg/kg i.m., Biowet,
Puławy; and xylazine hydrochloride 1mg/kg i.m., Riemser),
we performed bone marrow aspiration.
Bone marrow harvesting
We used the Mini Marrowstim™ Concentration System
(BIOMET). Each time, a bone marrow biopsy was per-
formed from the posterior iliac spine to aspirate 30ml of
specimen (3ml of heparin with 27ml of bone marrow as-
pirate). The specimens were centrifuged for 15min at 3200
rpm, yielding a 3-layer distribution consisting of a plasma-
rich layer, a cell-rich layer, and a red blood cell layer.
Cell-rich concentrate preparation
The isolated cell-rich concentrate was rinsed with Ham’s
F12. The gained solution was then centrifuged twice at
200 x g for 5 min and rinsed each time with Ham’s F12.
Growth plate chondrocyte isolation
Using the trepanning needle, which we used to aspirate
the bone marrow, we retrieved a biopsy of the iliac
growth cartilage, from which we isolated juvenile chon-
drocytes according to the following scheme: the growth
plate sample was cut into 1 mm3 fragments and then
washed with Ham’s F12 (PAN Biotech, P-04-14500).
The preparations were digested with Collagenase NB 4
(SERVA, 17454.02) at a concentration of 0.3 U/ml in
Ham’s F12 at 37 °C for 6 h. The solution was then centri-
fuged twice at 180×g for 10 min and rinsed each time
with Ham’s F12. The obtained cells were suspended in
100 μl of Ham’s F12 with 20% serum. For each prepar-
ation, we controlled the process of chondrocyte isolation
from the growth plate by microscopy.
Scaffold preparation
We cut the Hyalofast® scaffold into 20 equal fragments
similar to the predicted size of the joint cartilage defect.
We chose Hyalofast because in the degradation process,
hyaluronic acid is released into the lesion, creating a
microenvironment rich in HA. Moreover, MSCs com-
bined with Hyalofast have been shown to differentiate
into chondrocytes for hyaline-like cartilage regeneration
[13, 14]. We divided the scaffolds into two groups. In
the first group, after rinsing with Ham’s F12, the scaf-
folds were incubated with cell-rich concentrate for 5 h
and then with chondrocytes isolated from the iliac
growth plate for another 7 h. In the second group, the
scaffolds consisted only of scaffolds without added cells.
Thus, the prepared scaffolds were ready for implant-
ation. In stage II of the experiment in the operating the-
atre, after prior medication according to the scheme
shown above, the pigs were anaesthetized using 1% pro-
pofol 1.5–2.5 mg/kg i.v. (Fresenius Kabi, Austria GmbH)
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and fentanyl 2.5 mg/kg m.c. i.v. and inhaled isoflurane
0.5% volume.
Cartilage damage induction and scaffold implantation
While monitoring the vital parameters of the animals,
we performed a mini-arthrotomy separately for the right
and left knees. Each time, we made a cartilage defect on
the surface of the medial femoral condyle with a diam-
eter of 6 mm. We paid much attention to gentle and
thorough removal of the joint cartilage such that the
cavity reached the subchondral bone without secondary
damage. In one study group (CTRL), we implanted an
empty scaffold into the defect and to provide additional
cells for cartilage healing, and we perforated the sub-
chondral bone three times for each defect using a 1-
mm-diameter Kirschner wire to a depth of 6 mm. In the
second study group (CELLS), we implanted a scaffold in-
cubated with cells without drilling the subchondral bone.
The experimental scheme is presented in Tables 1 and
2. Every graft was checked prior to implantation to con-
firm the graft and animal number. Every graft was stabi-
lised with 2 vicryl 5–0 sutures (Johnson & Johnson).
After stable graft placement confirmation, we closed the
surgical wound and secured the operated limb with a
sterile dressing. The animals were allowed to walk freely
in their cages.
Morphological and histological evaluations
After 12 weeks from the day of surgery, the animals were
sacrificed (Morbitol 1.6 mg/kg i.v.), and the 20 treated
knees were collected. For each specimen, the patella was
removed to provide direct visualisation of the joint,
which facilitated morphological evaluation of the treated
cartilage according to the ICRS classification system
(Additional file 1: Table S1). The preparations were then
fixed in 10% formaldehyde. After sample decalcification
(using TBD-2) and sectioning the material containing re-
generated joint cartilage (5 μm thick), the histological
preparations were stained with haematoxylin and eosin,
Safranin O, and Masson’s trichrome. The histological re-
sults were independently evaluated by two pathologists
(RT, ŁW) using an Olympus BX51 microscope (Olym-
pus America, Inc., Melville, NY). The ICRS II scale
was used for the microscopic evaluation of regener-
ation (Additional file 2: Table S2).
Statistical analysis
To verify the difference between the mean measure-
ments in the two groups, i.e. treatment with scaffolds
containing cell-rich concentrate and chondrocytes (the
CELLS group) and scaffolds with no cells (the CTRL
group) for each parameter, we used Student’s t test and
the non-parametric Wilcoxon test based on Bayesian
statistics.
Results
In one pig (animal designated no. 4), postoperative
wound infection was observed. Due to confirmation of
the infectious process of the knee (morphologically and
histologically), preparations from 4R and 4L were ex-
cluded from further evaluations. Based on the obtained
results, both methods achieved good and very thera-
peutic effects. Macroscopic evaluation was performed
according to the ICRS classification system, and in the
group of joints treated with scaffolds without cells, all
specimens showed a nearly normal morphology, with an
average score of 9.66/12 points. In the group of joints
treated with scaffolds incubated with cells, all joints
similarly showed a nearly normal morphology, with an
average score of 10.44/12 points. Based on the micro-
scopic evaluation, 1 very good result and 8 good results
were obtained in the group of joints treated with scaf-
folds without cells, with an average of 70.44%; in the
group of joints treated with scaffolds incubated with
cells, 5 very good results and 4 good results were ob-
tained, with an average of 79.61%. The results were aver-
aged and are presented in Tables 3 and 4. The
histological evaluation revealed significantly better
Table 1 CTRL group–experiment scheme
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results in the CELLS group in terms of the tissue
morphology (p < 0.01), matrix staining (p < 0.01), tide-
mark formation (p < 0.001), and overall assessment (p <
0.05). The averaged results of all evaluated parameters
were better for the CELLS group, indicating a better
overall rating (p < 0.01). The results are shown in Table 5
and Fig. 1. More frequently, we found subchondral bone
abnormalities in the CTRL group. Notably, we did not
observe problems with graft integration in the CELLS
group, and basal integration in this group was signifi-
cantly better than that in the CTRL group (p < 0.01).
With the exception of one pig, we did not observe
lymphocytic infiltration as a response to scaffold im-
plantation. We found a correlation between increased
vascularization and a poorer overall rating, but it was
not statistically significant. The presence of chondrocyte
clusters in the two groups was analysed. By assessing the
preparations, we found more chondrocytes forming clus-
ters in the CELLS group (Table 6). Student’s t test
showed a statistically significant difference in the pres-
ence of clusters in the middle (p < 0.05) and marginal
zones (p < 0.01). The Wilcoxon test showed a statistically
significant difference in the same parameters identified
by Student’s t test and for clusters in the superficial
zone. According to Cohen’s d, the strength of the vari-
able for the middle and marginal zones was large, and
the strength for the superficial zone was average. The
results are shown in Table 7 and Fig. 2. Representative
results are shown in Figs. 3 and 4.
Discussion
Articular cartilage is a highly specialised tissue. Due to
poor vascularity, its regenerative abilities are very limited
[15]. Many authors have emphasised that despite various
treatment methods, it is not possible to restore articular
cartilage, only cartilage-like tissue [16–18].
In our experiment, we used 2-month-old Landrace
pigs. Due to relatively large animal size, we could per-
form less invasive and more precise surgical procedures.
Additionally, we could obtain growth plate chondro-
cytes. The similar tissue compliance genotype of this
model to those of humans will make it easier to relate
the results to the human population and implement the
tested method in clinical practice [17]. Children and
adolescents have a greater potential to spontaneous car-
tilage healing which correspond with better outcome.
Moreover, stem cells in children are present in greater
numbers and are much more able to divide than in
adults and that is why biological treatment is a good al-
ternative for immature patients. Indications for surgery
are comparable for children and adult patients, but due
to regeneration potential, there are no clear guidelines
Table 2 CELLS group–experiment scheme
Table 3 Macroscopic evaluation of cartilage according to ICRS
1L 2P 3L 5P 6P 7P 8P 9P 10P 1P 2L 3P 5L 6L 7L 8L 9L 10L
Degree of defect repair 3 3 3 3 3 3 3 3 3 3 4 3 3 3 4 3 3 3
Integration of border zone 4 4 4 3 4 3 4 4 3 4 4 4 4 4 4 4 4 4
Macroscopic appearance 3 3 3 2 2 3 3 4 4 4 4 3 3 2 3 4 4 3
Overall assessment 10 10 10 8 9 9 10 11 10 11 11 11 9 9 11 11 11 10
Scaffold with cells—CELLS + + + + + + + + +
Scaffold without cells—CTRL + + + + + + + + +
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designed for children. Type of surgery should always
depend on the size, the location, and the stage of the
cartilage defect. Determining study conditions, it is very
difficult to choose a relatively large cartilage defect size
to sufficiently reduce the possibility of spontaneous re-
generation because in skeletally immature animals, spon-
taneous repair almost always occurs. Based on
experiments carried out in mature animals, we chose the
cartilage defect size to reduce spontaneous cartilage re-
generation, and we gently removed the deep layer of ar-
ticular cartilage to reveal the subchondral bone [17, 18].
As a reference point, we chose to fill the defect with a
hyaluronic acid-based scaffold combined with drilling the
subchondral bone to provide marrow cells without
Table 4 Microscopic evaluation of cartilage according to ICRS
1L 2P 3L 5P 6P 7P 8P 9P 10P 1P 2L 3P 5L 6L 7L 8L 9L 10L
Tissue morphology 68 65 62 71 50.5 40 52 52 60 88 88 84 82.5 45 39 55 80 65
Matrix staining 79 53 55 75.5 32 59 34 47 25 90 89 90 94 30 59 61 68 45
Cell morphology 80 55 80 70 26.5 75 36 54 52 84 79 86.5 91.5 44 56 61.5 62 57
Chondrocyte clustering 40 48 55 65 56 62 60 55 65 45 50 65 55 52 55 52 55 56
Surface architecture 90 79 78 51.5 79.5 96 79 89 79 96 89 88 81 81 82 90 96 90
Basal integration. 90 88 89 75 77.5 85 82 73 82 95 95 94 85 81 84 92 91 85
Formation of tidemark 25 24 30 36 18 22 21 25 21 35 44 42 44 20 34 30 44 38
Subchondral bone abnormalities 84 55 89 48 47 70 90 65 88 93.5 95 95.5 89 76.5 65 91.5 95 96
Inflammation 100 100 100 62.5 82 100 82 75 97 100 100 100 77 80.5 92 89 95 100
Abnormal calcification/ossification 100 100 100 87 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Vascularization 86 20 95 70 52 50 42 45 70 100 92.5 96 94 50 48 55 95 75
Superficial assessment 81 60 72.5 70 45 72 62 62 80 92 91.5 91.5 91.5 38 67 60 72 75
Mid/deep zone assessment 80 62 75 75.5 61 75 71 66 76 89 92 89 82 75 50 83 84 85
Overall assessment 84 65 75 64 61 71 69 74 71 90 93 91.5 80 68 60 78 80 76
Scaffold with cells—CELLS + + + + + + + + +
Scaffold without cells—CTRL + + + + + + + + +
Table 5 Statistical analysis
t BF10 Z Cohen’s d 95% CI for Cohen’s d CELLS CTRL
Lower Upper M SD SE M SD SE
Tissue morphology 2.97** 4.04 − 2.134* 0.99 0.16 1.78 69.56 19.11 6.37 57.78 9.98 3.33
Cell morphology 2.23 2.23 − 1.96 0.74 − 0.02 1.47 69.56 22.82 7.61 51.11 18.82 6.27
Chondrocytes clustering − 1.00 − 1.00 − 0.91 − 033 − 1.00 0.35 69.11 16.50 5.50 58.67 19.25 6.42
Surface architecture 2.11 2.11 − 1.72 0.70 − 0.05 1.42 53.89 5.40 1.80 56.22 8.18 2.73
Basal integration 3.63** 3.64 − 2.55* 1.21 0.32 2.07 88.11 5.82 1.94 75.56 18.78 6.26
Formation of tidemark 6.29*** 6.29 − 2.67*** 2.10 0.88 3.28 89.11 5.37 1.79 82.44 6.15 2.05
Subchondral bone abnormalities 3.15* 3.15 − 2.43** 1.05 0.21 1.86 36.78 8.09 2.70 24.67 5.43 1.81
Inflammation 1.33 1,33 − 1.15 0.44 − 0.26 1.12 88.67 10.89 3.63 70.67 17.82 5.94
Abnormal calcification/ossification 1.00 – − 1.00 – – – 92.56 8.95 2.98 88.67 14.01 4.67
Vascularisation 2.28 2.28 − 2.08* 0.76 − 0.01 1.49 100.00 0.00 0.00 98.56 4.33 1.44
Surface/superficial assessment 1.80 1.80 − 1.48 0.60 − 0.13 1.30 78.33 21.71 7.24 58.89 23.46 7.82
Middle/deep zone assessment 1.97 1.97 − 1.72 0.66 − 0.09 1.36 75.56 18.78 6.26 67.11 11.22 3.74
Matrix staining 4.07** 4.07 − 2.38* 1.36 0.41 2.26 79.67 11.05 3.68 70.44 6.89 2.30
Overall assessment 2.59* 2.59 − 1.96* 0.86 0.07 1.62 81.00 12.63 4.21 71.33 6.78 2.26
Overall rating 3.388** 6.606 − 2.310* 1.129 0.259 1.959 76.55 9.83 328 66.91 6.76 2.25
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delivering them from another source (CTRL). This is simi-
lar to the microfracture technique, which is another mar-
row stimulation technique. The microfracture technique
is not a perfect technique because it does not restore hya-
line cartilage but leads to the production of fibrocarti-
lage [10, 11]. In the CELLS group, cells were obtained
from bone marrow aspirates. Thus, bone marrow cells
were present in both study groups. Chen et al. [19]
showed that the depth of subchondral bone drilling deter-
mines the quality of cartilage regeneration, which is why
we placed great importance on drilling the bone to a
depth of 6mm in our experiment. We have found many
papers confirming the beneficial effects of platelet-rich
plasma on the process of cartilage defect healing via the
microfracture technique with collagen scaffolds, fibrin
glue, or connective tissue membranes [20–22]. There are
also many papers confirming the beneficial effect of treat-
ment with mesenchymal stem cells (MSCs) obtained from
bone marrow aspirates (BMAs) [23–25], including one-
step techniques [26, 27]. Despite these reports, a few pro-
spective studies comparing cell transplantation with the
microfracture technique have not shown better results
with cell therapy [28–30]. By reviewing the literature, we
found reports that the chondrogenic potential of chondro-
cytes and chondrogenic stem cells declines with age,
which suggests the much higher regenerative potential of
juvenile chondrocytes [31–33]. This finding creates new
possibilities in cell therapy. However, there are few reports
of the use of these cells in clinical trials. In our experi-
ment, we accurately created the study groups to provide
almost identical conditions for comparison of the two
therapeutic methods. In contrast to Adkisson et al., as a
source of juvenile chondrocytes, we used growth cartilage
instead of articular cartilage. Based on our results, we con-
clude that both the microfracture technique and scaffolds
loaded with BMA-derived cells and growth plate chondro-
cytes achieve good results, with better results for the latter
approach (microfracture, average microscopic score—
Fig. 1 Differences between measurements for group with cells (CELL) and for group without cells (CTRL). Bars represent the mean results.
Significantly better parameters highlighted in red
Table 6 Numbers of clusters in specific cartilage layers
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70.44%; scaffolds with cells, average microscopic score—
79.61%). What is worth emphasising in terms of cartilage
regeneration is that we observed the formation of many
chondrocyte colonies or clusters. Regarding the histology
of cartilage, chondrocyte clusters are typical in osteoarth-
ritis [15, 16]. Other causes of cluster formation include ex-
cessive joint loading, articular cartilage damage, and joint
immobilisation [33–37]. After analysing a study reported
by Lotz et al. [38], we can explain the presence of these
clusters by the initial stage of the regeneration process
and the response of the newly created cartilage to mech-
anical loading. In the literature, there are reports of the
presence of chondrocyte clusters in cartilage models of re-
pair procedures. Makino et al. described the presence of
clusters in cartilage after treatment with osteochondral al-
lografts [39]. The main feature of clusters related to osteo-
arthritis versus cartilage regeneration is collagen type II
expression with no expression of collagen type I or X [40],
but we did not analyse this difference in our work. In ana-
logy to the results of a rabbit model [39], in our work, we
observed an increased number of clusters in the middle
and deep cartilage layers, which, in our opinion, is a mani-
festation of the cartilage repair process starting from the
deeper layers of the cartilage on the subchondral bone
side. Undoubtedly, the presence of chondrocyte clusters is
an interesting and not fully explained manifestation of the
cartilage response to the stress factor and requires further
observation. Based on our results, we believe that the
addition of immature chondrocytes provides new possibil-
ities for articular cartilage treatment.
Conclusions
1. Growth plate chondrocytes have a high
chondrogenic potential and could thus create new
possibilities for cartilage cell therapy.
2. The implantation of a hyaluronic acid scaffold
loaded with bone marrow-derived MSCs and
chondrocytes isolated from growth plates is a good
method for the treatment of cartilage defects in
immature patients.
Table 7 Statistical analysis
t BF10 Z Cohen’s d 95% CI for Cohen’s d CELLS CTRL
Lower Upper M SD SE M SD SE
Clusters superficial zone 2.15 1.53 − 2.023* 0.72 − 0.04 1.44 44.56 43.76 14.59 21.89 29.02 9.67
Clusters middle zone 2.704* 2.93 − 2.056* 0.90 0.10 1.67 41.67 23.18 7.73 22.22 13.94 4.65
Clusters deep zone 3.429** 6.94 − 2.201* 1.14 0.27 1.98 74.44 11.84 3.95 39.44 24.04 8.01




Fig. 2 Differences between number of chondrocyte clusters for group with cells (CELL) and for group without cells (CTRL). Bars represent the
mean results. Significantly better parameters highlighted in red
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Fig. 3 Knee 1P (treated with cells) a Macroscopic evaluation. b Microscopic view of chondrocyte clusters in regenerated cartilage (200×, H&E
staining) c Microscopic view of chondrocyte clusters in regenerated cartilage (Safranin O staining). d Microscopic view of chondrocyte clusters in
regenerated cartilage (Masson staining)
Fig. 4 Knee 1L (treated with microfracture technique) a Macroscopic evaluation. b Microscopic view of chondrocyte clusters in regenerated
cartilage (200×, H&E staining). c Microscopic view of chondrocyte clusters in regenerated cartilage (Safranin O staining). d Microscopic view of
chondrocyte clusters in regenerated cartilage (Masson staining)
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3. Cartilage repair based on the implantation of a
scaffold loaded with BMA-derived cells
supplemented with autologous growth plate
chondrocytes achieves better results than the
microfracture technique (overall microscopic
rating).
4. Chondrocyte clustering is a manifestation of the
cartilage repair process but requires further
observation.
Study limitations
1. The study group was relatively small (ten pigs).
2. Due to the small study group, there was no group
consisting of pigs with an untreated cartilage lesion
to assess potential for spontaneous regeneration.
Additional files
Additional file 1: Table S1. Cartilage repair assessment ICRS. (DOCX 18 kb)
Additional file 2: Table S2. ICRS II. (DOCX 19 kb)
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